Liver mass screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for benign liver mass. However, routine screening is recommended for individuals with chronic hepatitis B virus infection or cirrhosis from any cause who are at risk for development of HCC by ultrasound every 6 months.

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for benign liver mass. However, routine screening is recommended for individuals with chronic hepatitis B virus infection or cirrhosis from any cause who are at risk for development of HCC by ultrasound every 6 months. ^[1]

• Patients with Chronic Hepatitis B Virus Infection (HBsAg positivity)
  • Asian males over 40 years of age
  • Asian females over 50 years of age
  • Africans over 20 years of age
  • Patients with a family history of hepatocellular carcinoma
  • Patients with high HBV viral loads
  • Patients with evidence of active hepatitis
• Patients with Cirrhosis of Any Cause
  • Chronic hepatitis B
  • Chronic hepatitis C
  • Alcoholic cirrhosis
  • Non-alcoholic steatohepatitis
  • Hereditary hemochromatosis
  • Autoimmune hepatitis
  • Primary biliary cirrhosis
  • Alpha-1 antitrypsin deficiency